Evidence map›Paper›PMID 39183938›Full record

ArticleThe Journal of technology transfer2024

Public biofoundries as innovation intermediaries: the integration of translation, sustainability, and responsibility.

Andrew Watkins, Adam McCarthy, Claire Holland, Philip Shapira

Abstract read
In one paragraph

Article in The Journal of technology transfer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Andrew WatkinsManchester Institute of Innovation Research, Alliance Manchester Business School, The University of Manchester, Manchester, M13 9PL UK.ORCID 0000-0003-4500-3398
Adam McCarthyManchester Institute of Innovation Research, Alliance Manchester Business School, The University of Manchester, Manchester, M13 9PL UK.ORCID 0000-0003-0641-328X
Claire HollandManchester Institute of Innovation Research, Alliance Manchester Business School, The University of Manchester, Manchester, M13 9PL UK.ORCID 0000-0002-1537-9821
Philip ShapiraManchester Institute of Innovation Research, Alliance Manchester Business School, The University of Manchester, Manchester, M13 9PL UK.ORCID 0000-0003-2488-5985

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence and evolution of engineering biology, and its potential to address multiple global challenges is associated with the rise of biofoundries. These innovation intermediaries are facilities that employ advanced automation and computational analytics to accelerate engineering biology applications. Yet, for biofoundries to fully achieve their promise of generating applications that address grand societal challenges, they need to meet three key challenges: translation of research technology and its commercialization, attention to sustainability, and responsible innovation. Using web content analysis and interviews, this paper explores the functions and capabilities undertaken by existing public biofoundries, the extent to which they address these three challenges, and opportunities and models for enhancement. We also probe the roles undertaken by three other contrasting types of innovation intermediaries to identify practices and opportunities for integration and partnering with public biofoundries. We find that public biofoundries exhibit relatively strong capabilities for research translation, whereas efforts toward sustainability and responsibility are generally less prominent. For biofoundry enhancement, we propose an organisational model based on external partnering where public biofoundries are positioned as intermediaries within regional innovation systems. The framework put forward is reproducible and could be used in other contexts for assessing innovation intermediary organisational functions and capabilities toward meeting societal challenges.

Indexed as

Engineering biologyInnovation intermediariesPublic biofoundriesResponsibilitySustainabilityTranslation

Identifiers

PMID39183938
PMCPMC11341651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.